Kuros Biosciences Ag
(OTC) CSBTF
Kuros Biosciences Ag Financials at a Glance
Market Cap
$1.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
CHF 205.11M
Net Income (TTM)
-CHF 2.08M
EPS (TTM)
$0.06
P/E Ratio
398.28
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$25.57
Volume
120
Open
$25.57
Price
$25.57
Volume
120
Open
$25.57
Previous Close
$25.57
Daily Range
$25.57 - $25.57
52-Week Range
$22.72 - $42.81
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$25.57
Volume
120
Open
$25.57
Previous Close
$25.57
Daily Range
$25.57 - $25.57
52-Week Range
$22.72 - $42.81
Estimated Earnings Date
Aug 13, 2026
CSBTF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kuros Biosciences Ag
Industry
Biotechnology
Sector
Health CareEmployees
178
CEO
Christopher T. Fair
Website
kurosbio.comHeadquarters
Schlieren, ZH 8952, CH
CSBTF Financials
Key Financial Metrics (TTM)
Gross Margin
87.02%
Operating Margin
5.99%
Net Income Margin
1.26%
Return on Equity
2.28%
Return on Capital
10.73%
Return on Assets
1.53%
Earnings Yield
0.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
39.46M
Volume
120
Avg. Volume
355.968
Financials (TTM)
Gross Profit
CHF 174.77M
Operating Income
CHF 2.77M
EBITDA
CHF 9.64M
Operating Cash Flow
CHF 2.41M
Capital Expenditure
-CHF 3.21M
Free Cash Flow
-CHF 802.18K
Cash & ST Invst.
CHF 15.67M
Total Debt
CHF 1.39M
Kuros Biosciences Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CHF 66.07M
+219.2%
Gross Profit
CHF 56.40M
+223.7%
Gross Margin
85.36%
N/A
Market Cap
$1.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$5.67M
N/A
Employees
178
N/A
Net Income
CHF 3.65M
+142.1%
EBITDA
CHF 5.72M
+285.0%
Quarterly Fundamentals
Total Cash
CHF 15.67M
+10.3%
Total Debt
CHF 1.39M
-35.1%
Accounts Receivable
CHF 31.86M
+397.0%
Inventory
CHF 16.93M
+248.6%
Long Term Debt
CHF 737.00K
-52.9%
Short Term Debt
CHF 653.00K
+13.0%
Return on Assets
1.53%
N/A
Return on Invested Capital
10.51%
N/A
Free Cash Flow
CHF 914.82K
+139.2%
Operating Cash Flow
CHF 1.95M
+192.7%